Lobectomy or Sublobectomy for Small Non–Small-Cell Lung Cancer: The Question Remains The recent article in Journal of Clinical Oncology by Dai et al 1 explored the outcomes of lobectomy and of more ...

Cyclophosphamide Compared With Ifosfamide in Consolidation Treatment of Standard-Risk Ewing Sarcoma: Results of the Randomized Noninferiority Euro-EWING99-R1 Trial A retrospective data set including ...

Please provide your email address to receive an email when new articles are posted on . Lobectomy prolonged survival compared with sublobar resection for patients with T1a NSCLC tumors that were 2 cm ...

LOS ANGELES -- Surgeries to remove small tumors in stage IA non-small cell lung cancer (NSCLC) were associated with varying odds of long-term survival depending on the amount of lung removed, based on ...

New research presented at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting reveals that anatomic lung resections, such as lobectomy and segmentectomy, are associated with improved long-term ...

The recent presentation of the long-term results of the JCOG0802 phase 3 trial has sparked discussion within the international thoracic surgical community. Initial 5-year results in 2022 reported a ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Surgery is the preferred modality for the treatment of early ...

LOS ANGELES—January 25, 2025 New research presented at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting reveals that anatomic lung resections, such as lobectomy and segmentectomy, are ...

Dr. Nabil Rizk, chief of thoracic surgery at Hackensack University Medical Center, explains that segmentectomy is “just a little bit more of a refined way of treating cancers.” As surgical treatments ...

New research presented at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting shows that anatomic lung resections, including lobectomy and segmentectomy, offer better long-term survival rates ...

Pulmonary resection is the first line of treatment of stage I and II non-small cell lung cancer (NSCLC). It is also important as part of the management of stage IIIA. In early stages of NSCLC, the ...